Tag: Philadelphia

Imvax Charges Ahead with Phase IIb Glioblastoma Trial

Philadelphia-based Imvax recently announced it had dosed the first patient in it...

SVB Collapse Appears to Only Have Minor Ripples for Bio...

While the impact for this event might not be as bad as anticipated, it sends a w...

In Conversation With Gilda D'Incerti, Founder and CEO o...

In celebration of International Women's Day, BioBuzz caught up with D'Incerti to...

In a Recent M&A Desert, Philly Proves to Be an Oasis

More on the latest Philly M&AS: Adaptimmune and TCR2; Kite and Tmunity.

A Mother’s Journey, a Biotech for Her Daughter

Michelle Teng, Ph.D., says that her eldest daughter, Sofia, “had a very normal c...

March 2023 - Philadelphia Cell & Gene Therapy Meetup

BioBuzz’s second meetup in Philly, we can’t wait to see you (again) in the City ...

Kyle Flannigan and the Kinder COVID Vaccine

US Specialty Formulations is working to create an oral, thermo-stable COVID vacc...

This New Jersey Biotech is Tackling the Rise of Concern...

“Last of Us” fans take note – while there isn’t a fungi-fueled zombie apocalypse...

Gattuso Development and Drexel University Break Ground ...

The 11-story, 520,000 sq. ft. project reaffirms city’s role as a hub for life sc...

Historic Quartermaster Campus to be Converted to New R&...

The new site, renamed the Quartermaster Science + Technology Park, is currently ...